209 related articles for article (PubMed ID: 37193692)
21. Pesticides and Parkinson's disease--is there a link?
Brown TP; Rumsby PC; Capleton AC; Rushton L; Levy LS
Environ Health Perspect; 2006 Feb; 114(2):156-64. PubMed ID: 16451848
[TBL] [Abstract][Full Text] [Related]
22. A single cell high content assay detects mitochondrial dysfunction in iPSC-derived neurons with mutations in SNCA.
Little D; Luft C; Mosaku O; Lorvellec M; Yao Z; Paillusson S; Kriston-Vizi J; Gandhi S; Abramov AY; Ketteler R; Devine MJ; Gissen P
Sci Rep; 2018 Jun; 8(1):9033. PubMed ID: 29899557
[TBL] [Abstract][Full Text] [Related]
23. Induced dopaminergic neurons: A new promise for Parkinson's disease.
Xu Z; Chu X; Jiang H; Schilling H; Chen S; Feng J
Redox Biol; 2017 Apr; 11():606-612. PubMed ID: 28110217
[TBL] [Abstract][Full Text] [Related]
24. Induced pluripotent stem cells: a tool for modeling Parkinson's disease.
Bose A; Petsko GA; Studer L
Trends Neurosci; 2022 Aug; 45(8):608-620. PubMed ID: 35667922
[TBL] [Abstract][Full Text] [Related]
25. Generation of a human induced pluripotent stem cell line derived from a Parkinson's disease patient carrying SNCA duplication.
Suzuki H; Egawa N; Kondo T; Imamura K; Enami T; Tsukita K; Suga M; Shibukawa R; Okanishi Y; Uchiyama T; Inoue H; Takahashi R
Stem Cell Res; 2020 May; 45():101828. PubMed ID: 32413791
[TBL] [Abstract][Full Text] [Related]
26. Elucidating Conserved Transcriptional Networks Underlying Pesticide Exposure and Parkinson's Disease: A Focus on Chemicals of Epidemiological Relevance.
Cao F; Souders Ii CL; Perez-Rodriguez V; Martyniuk CJ
Front Genet; 2018; 9():701. PubMed ID: 30740124
[TBL] [Abstract][Full Text] [Related]
27. Generation of three induced pluripotent stem cell lines from a Parkinson's disease patient with mutant PARKIN (p. C253Y).
Tariq M; Liu H; Ibañez DP; Li Y; Chen S; Jiang M; Fan W; Zhao P; Luo Z; Wang D; Kanwal S
Stem Cell Res; 2020 May; 45():101822. PubMed ID: 32387897
[TBL] [Abstract][Full Text] [Related]
28. Association of Parkinson's Disease and Its Subtypes with Agricultural Pesticide Exposures in Men: A Case-Control Study in France.
Moisan F; Spinosi J; Delabre L; Gourlet V; Mazurie JL; Bénatru I; Goldberg M; Weisskopf MG; Imbernon E; Tzourio C; Elbaz A
Environ Health Perspect; 2015 Nov; 123(11):1123-9. PubMed ID: 25815770
[TBL] [Abstract][Full Text] [Related]
29. Induced pluripotent stem cell (iPSC)-derived dopaminergic models of Parkinson's disease.
Beevers JE; Caffrey TM; Wade-Martins R
Biochem Soc Trans; 2013 Dec; 41(6):1503-8. PubMed ID: 24256244
[TBL] [Abstract][Full Text] [Related]
30. Protective glove use and hygiene habits modify the associations of specific pesticides with Parkinson's disease.
Furlong M; Tanner CM; Goldman SM; Bhudhikanok GS; Blair A; Chade A; Comyns K; Hoppin JA; Kasten M; Korell M; Langston JW; Marras C; Meng C; Richards M; Ross GW; Umbach DM; Sandler DP; Kamel F
Environ Int; 2015 Feb; 75():144-50. PubMed ID: 25461423
[TBL] [Abstract][Full Text] [Related]
31. Pesticide use and incident Parkinson's disease in a cohort of farmers and their spouses.
Shrestha S; Parks CG; Umbach DM; Richards-Barber M; Hofmann JN; Chen H; Blair A; Beane Freeman LE; Sandler DP
Environ Res; 2020 Dec; 191():110186. PubMed ID: 32919961
[TBL] [Abstract][Full Text] [Related]
32. Modeling Parkinson's Disease Using Patient-specific Induced Pluripotent Stem Cells.
Li H; Jiang H; Zhang B; Feng J
J Parkinsons Dis; 2018; 8(4):479-493. PubMed ID: 30149462
[TBL] [Abstract][Full Text] [Related]
33. From 2D to 3D: Development of Monolayer Dopaminergic Neuronal and Midbrain Organoid Cultures for Parkinson's Disease Modeling and Regenerative Therapy.
Yeap YJ; Teddy TJW; Lee MJ; Goh M; Lim KL
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768843
[TBL] [Abstract][Full Text] [Related]
34. Decreased Sirtuin Deacetylase Activity in LRRK2 G2019S iPSC-Derived Dopaminergic Neurons.
Schwab AJ; Sison SL; Meade MR; Broniowska KA; Corbett JA; Ebert AD
Stem Cell Reports; 2017 Dec; 9(6):1839-1852. PubMed ID: 29129681
[TBL] [Abstract][Full Text] [Related]
35. Molecular Features of Parkinson's Disease in Patient-Derived Midbrain Dopaminergic Neurons.
Ren Y; Jiang H; Pu J; Li L; Wu J; Yan Y; Zhao G; Guttuso TJ; Zhang B; Feng J
Mov Disord; 2022 Jan; 37(1):70-79. PubMed ID: 34564901
[TBL] [Abstract][Full Text] [Related]
36. Generation of Naivetropic Induced Pluripotent Stem Cells from Parkinson's Disease Patients for High-Efficiency Genetic Manipulation and Disease Modeling.
Hu Z; Pu J; Jiang H; Zhong P; Qiu J; Li F; Wang X; Zhang B; Yan Z; Feng J
Stem Cells Dev; 2015 Nov; 24(21):2591-604. PubMed ID: 26218671
[TBL] [Abstract][Full Text] [Related]
37. Stemming the hype: what can we learn from iPSC models of Parkinson's disease and how can we learn it?
Jacobs BM
J Parkinsons Dis; 2014; 4(1):15-27. PubMed ID: 24398656
[TBL] [Abstract][Full Text] [Related]
38. Modeling Parkinson's disease using induced pluripotent stem cells.
Byers B; Lee HL; Reijo Pera R
Curr Neurol Neurosci Rep; 2012 Jun; 12(3):237-42. PubMed ID: 22538490
[TBL] [Abstract][Full Text] [Related]
39. Pluripotent stem cell derived dopaminergic subpopulations model the selective neuron degeneration in Parkinson's disease.
Oosterveen T; Garção P; Moles-Garcia E; Soleilhavoup C; Travaglio M; Sheraz S; Peltrini R; Patrick K; Labas V; Combes-Soia L; Marklund U; Hohenstein P; Panman L
Stem Cell Reports; 2021 Nov; 16(11):2718-2735. PubMed ID: 34678205
[TBL] [Abstract][Full Text] [Related]
40. Impairment of proteasome and anti-oxidative pathways in the induced pluripotent stem cell model for sporadic Parkinson's disease.
Chang KH; Lee-Chen GJ; Wu YR; Chen YJ; Lin JL; Li M; Chen IC; Lo YS; Wu HC; Chen CM
Parkinsonism Relat Disord; 2016 Mar; 24():81-8. PubMed ID: 26797011
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
